Skip to content 
š§¬ Beyond the Shelf: How Synthetic Biology Startups Are Disrupting Traditional CPG Supply ChainsĀ
The Day Biotech Derailed a Household Brandās Go-to-Market PlanĀ In late 2024, a global CPG giant delayed its launch of a plant-based skincare line in Europe. The reason? A small synthetic biology startup had already partnered with two regional retailers, offering lab-grown ingredients with superior efficacy and sustainability claimsāat 20% lower cost. What shocked the ā¦
Hi, This is Emma. Letās get the conversation started!